Frontiers in Neuroscience, published by FRONTIERS MEDIA SA, is a premier open-access journal dedicated to advancing our understanding of the nervous system through innovative and rigorous research. Since its inception in 2007, this journal has become an influential platform for researchers, featuring a diverse range of topics across various subfields of neuroscience. With its current ranking in the second quartile (Q2) of the category "Neuroscience (miscellaneous)" and a commendable position of #40 out of 113 in general neuroscience according to Scopus, Frontiers in Neuroscience is recognized for its high-impact contributions. The journal promotes free access to scholarly work, ensuring that cutting-edge neuroscience studies reach a global audience and foster collaboration across disciplines. By bridging gaps in knowledge and facilitating the exchange of ideas, Frontiers in Neuroscience plays a pivotal role in addressing the complexities of the nervous system and its effects on behavior, cognition, and health.

NEUROPHYSIOLOGY, published by SPRINGER, is a distinguished journal dedicated to advancing the understanding of neural function and physiological processes across a broad spectrum of topics. With a rich history dating back to 1969, this journal has been instrumental in disseminating pivotal research findings and theoretical advancements within the fields of neuroscience and physiology. Although it currently ranks in the fourth quartile of both the Neuroscience (miscellaneous) and Physiology categories, this journal remains a valuable resource for researchers and professionals seeking to explore innovative methodologies and address critical issues within neurophysiological studies. While NEUROPHYSIOLOGY does not offer open access options, its latest research continues to provide insights and stimulate discussions essential for education and ongoing inquiry. Publishers and contributors to this journal contribute to a growing repository of knowledge right from the heart of the United States.

CURRENT OPINION IN NEUROBIOLOGY, published by CURRENT BIOLOGY LTD, stands as a premier interdisciplinary journal in the field of neuroscience, specifically focusing on the latest advancements and emerging trends in neurobiology. With an impressive impact factor bolstered by its classification in Q1 in the Neuroscience (Miscellaneous) category and a notable Scopus rank of #16 out of 113 within General Neuroscience, this journal serves as an essential resource for academics, professionals, and students alike. Since its inception in 1991, CURRENT OPINION IN NEUROBIOLOGY has consistently provided insightful reviews covering various aspects of neurobiological research, thereby enhancing our understanding of complex neural processes. While the journal is not open access, it remains committed to disseminating high-quality research and fostering scholarly dialogue, making it a critical platform for those seeking to keep abreast of the dynamic developments in neuroscience.

Frontiers in Systems Neuroscience is a premier open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the complex systems that underpin neural function and behavior. Established in 2007 and based in Switzerland, this journal has gained recognition for its rigorous peer-reviewed articles that contribute significantly to the fields of Cellular and Molecular Neuroscience, Cognitive Neuroscience, and Developmental Neuroscience. As of 2023, it proudly holds a Q2 ranking in several neuroscience categories, reflecting its high impact and relevance in the academic community. The journal is accessible to researchers, professionals, and students worldwide, providing a platform for innovative research while promoting collaborative scientific dialogue. With a commitment to open access, Frontiers in Systems Neuroscience ensures that groundbreaking findings are readily available to enhance knowledge sharing across the globe. This makes it an essential resource for anyone looking to stay at the forefront of neuroscience research.

Frontiers in Human Neuroscience is a premier open access journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the complexities of human neuroscience. With an ISSN of 1662-5161, the journal has established its prominence in various fields, achieving a Q2 ranking in categories such as Behavioral Neuroscience, Neuropsychology and Physiological Psychology, and Psychiatry and Mental Health as of 2023. Since its inception in 2008, Frontiers in Human Neuroscience has consistently contributed to the scholarly dialogue by offering a platform for innovative research that bridges the gap between neuroscience and behavioral science. The journal's rigorous peer-review process and commitment to open access ensures that findings are readily available, promoting collaboration and progress within the academic community. With an impact on neuroscience disciplines, it stands at the forefront of the field, inviting researchers, professionals, and students alike to engage with cutting-edge studies and developments. The journal's address is located in Lausanne, Switzerland, where it continues to flourish as a hub for neurobiological exploration.

Experimental Neurobiology is a prominent academic journal published by the Korean Society for Brain and Neural Science and the Korean Society for Neurodegenerative Disease, dedicated to advancing the field of neurobiology. With an ISSN of 1226-2560 and an E-ISSN of 2093-8144, this journal plays a pivotal role in disseminating innovative research findings from 2015 to 2024. The journal has established its relevance within the scientific community, achieving a Q3 ranking in Cellular and Molecular Neuroscience and a Q2 ranking in Neurology (Clinical) as of 2023. Researchers exploring the complexities of neurobiology will find a platform for their findings, as it currently holds a rank of #182 in clinical neurology and #73 in cellular and molecular neuroscience within the Scopus database. Although open access is not presently available, the journal remains committed to academic excellence and provides a critical resource for those engaged in the study of neurological diseases and mechanisms.

NEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.

eNeuro is a prominent open-access journal published by the Society for Neuroscience, dedicated to advancing the field of neuroscience through the dissemination of high-quality research. Launched in 2015, it reflects its commitment to accessibility by providing a platform for innovative studies and advancements in neurobiology. The journal holds a strong reputation, achieving a Q1 ranking in Medicine (miscellaneous) and a Q2 in Neuroscience (miscellaneous) as of 2023, with Scopus rankings placing it at #56 out of 113 in General Neuroscience, marking it in the 50th percentile. With its convergence to cover articles from 2014 to 2024, eNeuro continues to serve as a vital resource for researchers, professionals, and students alike, offering a comprehensive hub for the latest discoveries and theoretical developments in neuroscience. As part of its mission, eNeuro aims to foster collaboration and inspire the academic community with openly accessible content, making significant contributions to scientific discourse.

Frontiers in Neural Circuits is a leading open-access journal dedicated to the rapidly advancing field of neuroscience, published by FRONTIERS MEDIA SA in Switzerland. Established in 2007, the journal has made significant strides in disseminating cutting-edge research through its commitment to open access, ensuring that groundbreaking discoveries are freely available to researchers, professionals, and students worldwide. With an impressive reputation, it occupies Q1 status across multiple categories, including Cellular and Molecular Neuroscience and Cognitive Neuroscience, reflecting its impact in these areas. Furthermore, its notable rankings within Scopus place it among the top journals, emphasizing its importance and influence, particularly in the domains of Sensory Systems and Neuroscience as a whole. By focusing on new findings related to neural circuitry and its implications for cognitive processes, Frontiers in Neural Circuits serves as an essential resource for anyone vested in advancing knowledge and understanding in the intricate field of neuroscience.

Welcome to Molecular Neurobiology, the premier journal dedicated to the exploration of the molecular mechanisms underlying nervous system function and pathophysiology. Published by Springer, this journal provides an essential platform for disseminating high-quality research in the rapidly evolving fields of Cellular and Molecular Neuroscience and Neurology, boasting an impressive impact factor that reflects its esteemed position within the academic community. With its ranking in the Q1 and Q2 quartiles for various neuroscience categories, Molecular Neurobiology stands at the forefront of groundbreaking discoveries, showcasing innovative studies that bridge basic science and clinical application. Researchers and professionals are invited to contribute to its rich portfolio, which spans from fundamental insights into cellular processes to advanced therapeutic strategies. Although Molecular Neurobiology does not operate as an Open Access journal, its influential body of work remains accessible through institutional and personal subscriptions. As we converge from 1987 to 2024, we continue to aim for excellence, seeking to catalyze progress in understanding neurological diseases and enhance the scientific dialogue within the neuroscience community.